How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Keep Reading →
March 8 - Hedge Funds, News
Last week, US stocks dropped firmly and settled in the connection territory as threat from the coronavirus pandemic wreaked havoc among investors.
Keep Reading →
March 4 - Market Movers, News
It has been a fantastic year for equity investors as Donald Trump pressured Federal Reserve to reduce interest rates and finalized the first leg of a trade deal with China.
Keep Reading →
December 29 - Hedge Funds, News
"The global economic environment is very favorable for investors. Economies are generally strong, but not too strong.
Keep Reading →
November 30 - Hedge Funds, News
The financial regulations require hedge funds and wealthy investors that crossed the $100 million equity holdings threshold to file a report that shows their positions at the ...
Keep Reading →
October 9 - Hedge Funds, News
Hedge fund managers like David Einhorn, Bill Ackman, or Carl Icahn became billionaires through reaping large profits for their investors, which is why piggybacking their stock...
Keep Reading →
June 6 - Hedge Funds, News
"Market volatility has picked up again over the past few weeks.
Keep Reading →
March 27 - Hedge Funds, News
It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity.
Keep Reading →
December 8 - Hedge Funds, News
Numerous billionaire money managers, including the likes of Warren Buffett and Ken Fisher, absolutely love dividend stocks (check out a list of Ken Fisher's favorite dividend ...
Keep Reading →
December 7 - Dividend Stocks, Hedge Funds, News
The biotech sector is well known for its M&A activity, but billionaire fund managers don’t seem to be attracted by the frenzy.
Keep Reading →
February 5 - Hedge Funds, News
Quantitative funds are gaining more ground among hedge funds in terms of trading volume and inflow of capital.
Keep Reading →
December 28 - Hedge Funds, News, Quantitative Investing
Out of hundreds of healthcare stocks that are trading on the U.S stock market, we have selected the top 75 healthcare dividend stocks to invest in.
Keep Reading →
July 17 - Dividend Stocks, News
If you're seeking to invest in stocks with great long-term potential and are interested in adding some exposure to the healthcare sector, then the 15 biggest healthcare companies...
Keep Reading →
July 6 - News
The 11 best growth company stocks to buy now are often characterized by strong sales growth, solid management team, attractive valuations, and a growing market for their products...
Keep Reading →
June 12 - Hedge Funds, News
Healthcare is a vast sector that nonetheless has huge growth prospects, with the U.S government and its citizens spending about $3 trillion annually in an attempt to stay healthy...
Keep Reading →
May 3 - Hedge Funds, News
What are the 11 Most Profitable Companies In The Fortune 500? Membership in the Fortune 500 is one of the most prestigious honors a company can have.
Keep Reading →
April 23 - Lists, News
If, back in 2013, you invested in at least one of the 11 fastest growing S&P 500 companies in America, chances are that you are one happy (and possibly much wealthier) shareholder...
Keep Reading →
April 4 - Lists, News
Dividends are an investor's best friend.
Keep Reading →
March 16 - Hedge Fund Analysis, News
2016 was not a very good year for biotech stocks to say the least.
Keep Reading →
March 10 - News, Stock Analysis
Healthcare stocks generally offer good dividend yields and a safe stream of cash flow given the recession-proof nature of the industry.
Keep Reading →
March 8 - Hedge Funds, News
Public access for Gilead Sciences, Inc. (NASDAQ:GILD) EPCLUSA will be provided in Ontario to adults who need the drug for the hepatitis C treatment.
Keep Reading →
February 23 - News, Stock Analysis
The 10 most generous companies in the US are familiar and well-known names.
Keep Reading →
February 3 - Dividend Stocks, Lists, News
There are almost too many speculations of changes to come in Washington, D.C.
Keep Reading →
January 23 - News, Stock Analysis
A federal judge in Pennsylvania has admonished the state for restricting inmates’ access to drugs and particularly those for hepatitis C.
Keep Reading →
January 5 - News, Stock Analysis
While most westerners don’t have to worry about hepatitis B virus (HBV) due to currently available and effective vaccines, HBV is still an incurable disease, with a staggering...
Keep Reading →
December 28 - News, Stock Analysis
Apple Inc. shares currently trade at a trailing price earnings ratio of 14.
Keep Reading →
December 24 - Hedge Fund Analysis, Hedge Funds, News
After a strong 2015, health care stocks are leading the way lower in 2016. And it’s been an even uglier year for biotechnology company Gilead Sciences, Inc.
Keep Reading →
December 23 - News, Stock Analysis
Up to now, I have been very vocal with respect to my bullish opinion regarding Gilead Sciences, Inc.
Keep Reading →
December 22 - News, Stock Analysis
Efforts by GlaxoSmithKline plc (ADR) (NYSE:GSK) in carrying out a large study on its new HIV drug are yielding positive results.
Keep Reading →
December 21 - News, Stock Analysis
A New Drug Application (NDA) by AbbVie Inc (NYSE:ABBV) that will be used for the treatment of Hepatitis C is at the mercy the U.S. Food and Drug Administration.
Keep Reading →
December 21 - News, Stock Analysis
Here’s a breakdown on how the Magic Formula Portfolio is performing.
Since beginning this Shadow Stock Portfolio on June 1, 2016, it owns six stocks and is 60% invested.
The return on the invested capital is 5.
Keep Reading →
December 9 - News, Stock Analysis
The election of Donald Trump has heralded an era of optimism in the healthcare industry, which has been one of the worst performing sectors over the past two years.
Keep Reading →
December 4 - Hedge Fund Analysis, Hedge Funds, News
Gilead Sciences, Inc. (NASDAQ:GILD) has switched course and has begun aggressive marketing of its HIV drug Truvada as a preventative medicine for HIV-negative healthy people.
Keep Reading →
December 1 - News, Stock Analysis
Gilead Sciences, Inc. (NASDAQ:GILD) might as well have quashed rumors making waves claiming it is planning to acquire Belgium-based Galapagos NV (ADR) (NASDAQ:GLPG).
Keep Reading →
November 29 - News, Stock Analysis
We at Insider Monkey have gone over 700 13F filings that hedge funds and prominent investors are required to file by the SEC.
Keep Reading →
November 24 - Hedge Funds, News
In most cases a new method of drug delivery can occasionally alter markets a bit and cause some shifts. In rare cases though, it can fundamentally change an entire sector.
Keep Reading →
November 23 - News, Stock Analysis
GlobeImmune Inc (OTCMKTS:GBIM) shareholders did not have a good week last week.
Keep Reading →
November 21 - News, Stock Analysis
Today, I’m going to post some charts on a few trade setups that I’m focused on and which may provide a trade or two over the coming sessions.
Keep Reading →
November 15 - News, Stock Analysis
ValueWorks LLC is a New York-based, value-focused long/short equity hedge fund founded in 2001 by Charles Lemonides, a CFA who previously served as the Chief Investment Officer...
Keep Reading →
November 15 - Hedge Fund Analysis, Hedge Funds, News
Investors are growing bearish on hedge funds due to sloppy performance and high fees, but our research proves that long sides of the smart money's portfolio always return optimistic...
Keep Reading →
November 14 - Hedge Funds, News, Tech
Legendary investor Julian Robertson, founder of Tiger Management, sees tremendous upside in biotech stocks right now. The billionaire told CNBC in a recent interview that fears...
Keep Reading →
October 29 - ETF Trading, Hedge Fund Analysis, Hedge Funds, News, Tech
All three indexes are in the green today after U.S. consumer confidence jumped to its highest figure in nine years during September.
Keep Reading →
September 27 - Market Movers, News
Equities have rebounded in trading today following the sell-off on Tuesday.
Keep Reading →
September 14 - News, Stock Analysis
The US stock market is mixed on Tuesday amid news in the M&A space and Institute for Supply Management's data that showed non-manufacturing index slump to 51.4, the lowest ...
Keep Reading →
September 6 - Market Movers, News
In this article we'll take a look at why VeriFone Systems Inc (NYSE:PAY), Dynavax Technologies Corporation (NASDAQ:DVAX), Gilead Sciences, Inc.
Keep Reading →
September 5 - Market Movers, News
Times are tough for healthcare stocks as investors keep a distance from the sector following drug-pricing control concerns and political clamor.
Keep Reading →
August 29 - Hedge Funds, News
Crude futures are again in the red as traders prepare for another API inventory release later today.
Keep Reading →
July 26 - Market Movers, News
The highly anticipated quarterly 13F filings for the second quarter of 2016 are slowing flowing in, enabling retail investors and analysts to examine the equity portfolios of ...
Keep Reading →
July 22 - Hedge Fund Analysis, Hedge Funds, News
For the section of our report detailing events in biotech this past couple of weeks, we’ve got two focus companies – one big, one small. They are Gilead Sciences, Inc.
Keep Reading →
July 7 - News, Stock Analysis
Healthcare stocks, along with food and drink-related securities, are usually recommended as defensive holdings for recessions and bear markets, as individuals have to eat, drink...
Keep Reading →
July 5 - Hedge Funds, News